Metabolism of administered triethylene tetramine dihydrochloride in humans

Life Sciences

Volumn 61, Issue 9, 1997, Pages 899-907

  Kodama, Hiroko ^a   Murata, Yoshiko ^a   Iitsuka, Taketoshi ^a   Abe, Toshiaki ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

1 N acetyltriethylene tetramine; Copper; Triethylene tetramine dihydrochloride (trien 2HCl); Wilson's disease

Indexed keywords

CHELATING AGENT; COPPER; DRUG METABOLITE; IRON; TRIENTINE; ZINC;

ADULT; ARTICLE; CHELATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EXCRETION; DRUG METABOLISM; DRUG URINE LEVEL; FAST ATOM BOMBARDMENT MASS SPECTROMETRY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PROTON NUCLEAR MAGNETIC RESONANCE; URINARY EXCRETION; WILSON DISEASE;

ADMINISTRATION, ORAL; ADULT; CHELATING AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COPPER; FEMALE; HUMANS; IRON; MAGNETIC RESONANCE SPECTROSCOPY; MALE; SPECTROMETRY, MASS, FAST ATOM BOMBARDMENT; TRIETHYLENETETRAMINE; ZINC;

EID: 0030791354     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(97)00592-4     Document Type: Article

References (20)

1. H. KODAMA, Toxicology of Metals, L.W. Chang (Ed), 371-386, CRC Press, Boca Raton (1996).
2. W. STREMMEL, K.W. MEYERROSE, C. NIEDERAU, H. HEFTER, G. KREUZPAINTNER and G. STROHMEYER, Ann. Int. Med. 115 720-726 (1991).
3. J.C. YARZE, P. MARTIN, S.J. MUNOZ and L.S. FRIEDMAN, Am. J. Med. 92 643-54 (1992).
4. J.M. WALSHE, Lancet 1 1401-1402 (1969).
5. R.H.A. HASLAM, A. SASS-KORTSAK, W. STOUT and M. BERG, Dev. Pharmacol. Ther. 1318-324 (1980).
6. G.J. BREWER and V. YUZBASIYAN-GURKAN, Dig. Dis. 7 178-193 (1989).
7. J.M. WALSHE, Lancet 1 643-647 (1982).
8. I.H. SCHEINBERG, M.E. JAFFE and I. STERNLIEB, New Engl. J. Med. 317 209-213 (1987).
9. L.CONDAMINE, O. HERMINE, P. ALVIN, M. LEVINE, C. REY and V. COURTECUISSE, Br. J. Haematol. 83 166-168 (1993).
10. T. DAHLMAN, P. HARTVIG, M. LOFHOLM, H. NORDLINDER, L. LOOF and K. WESTERMARK, Quart. J. Med. 88 609-616 (1995).
11. A.R. PERRY, A. PAGLIUCA, E.J. FITZSIMONS, G.J. MUFTI and R. WILLIAMS, Int J. Hematol. 64 69-72 (1996).
12. J.M. WALSHE, Quart. J. Med. N.S. 167 441-452 (1973).
13. M.M. JONES, P.K. SINGH and L.J. ZIMMERMAN, Chem. Res. Toxicol. 8 942-948 (1995).
14. A. MCQUAID and J. MASON, J. Inorg. Biochem. 41 87-92 (1990).
15. H. KODAMA, Y. MEGURO, A. TSUNAKAWA, Y. NAKAZATO, T. ABE and H. MURAKITA, Tohoku. J. Exp. Med. 169 59-66 (1993).
16. K.R. GIBBS and L.M. WALSHE, Orphan diseases and orphan drugs I.H. SCHEINBERG and J.M. WALSHE (eds), 33-42, Manchester University Press, London (1986).
17. H. SAITO, K. WATANABE, M. SAHARA, R. MOCHIZUKI, K. EDO and Y. OHYAMA, Tohoku. J. Exp. Med. 164 29-35 (1991).
18. J. MORITA, M. YOSHINO, H. WATARI, I. YOSHIDA, T. MOTOHIRO, F. YAMASHITA, Y. OKANO and T. HASHIMOTO, Dev. Pharmacol. Ther. 19 6-9 (1992).
19. S.R. LÖNER, K. GÜNTHER, H.J. KÜHN and H. BACHMANN, Acta. Neurol. Scand. 83 364-366 (1991).
20. R.S. DUBOIS, D.O. RODGERSON and M. HAMBIDGE, J. Pediatr. Gastroenterol. Nutr. 10 77-81 (1990).